OBJECTIVE: Perivascular fat through the secretion of paracrine and pro-inflammatory mediators may play a role in obesity-mediated vascular disease. We sought to examine associations between adipose tissue depots immediately surrounding the thoracic aorta, metabolic risk factors, and vascular calcification. METHODS: In participants free of cardiovascular disease (CVD) from the Framingham Heart Study Offspring cohort who underwent computed tomography (n=1067, mean age 59 years, 56.1% women), thoracic peri-aortic fat depots were quantified. Visceral abdominal tissue (VAT) and calcification of the thoracic and abdominal aorta were also measured. RESULTS: Peri-aortic fat depots were correlated with body mass index, waist circumference (WC), VAT (all p<0.0001), hypertension (p=0.007), low HDL (p<0.0001), serum triglycerides (p<0.0001), impaired fasting glucose (p=0.005), and diabetes (p=0.02). These associations generally remained significant after adjustment for BMI and WC (all p-values<0.05), but not after VAT adjustment. Thoracic aortic fat was associated with thoracic calcification in models containing VAT (OR 1.31, 95% CI 1.01-1.71, p=0.04), but was not significant after adjustment for CVD risk factors (OR 1.16, 95% CI 0.88-1.51, p=0.30). Thoracic aortic fat, however, was associated with abdominal aortic calcification (OR 1.48, 95% CI 1.11-1.98, p=0.008) and coronary artery calcification (OR 1.47, 95% CI 1.09-1.98, p=0.001) even in models including CVD risk factors and VAT. CONCLUSIONS: Thoracic peri-aortic fat is associated with measures of adiposity, metabolic risk factors, and coronary and abdominal aortic calcification.
OBJECTIVE: Perivascular fat through the secretion of paracrine and pro-inflammatory mediators may play a role in obesity-mediated vascular disease. We sought to examine associations between adipose tissue depots immediately surrounding the thoracic aorta, metabolic risk factors, and vascular calcification. METHODS: In participants free of cardiovascular disease (CVD) from the Framingham Heart Study Offspring cohort who underwent computed tomography (n=1067, mean age 59 years, 56.1% women), thoracic peri-aortic fat depots were quantified. Visceral abdominal tissue (VAT) and calcification of the thoracic and abdominal aorta were also measured. RESULTS:Peri-aortic fat depots were correlated with body mass index, waist circumference (WC), VAT (all p<0.0001), hypertension (p=0.007), low HDL (p<0.0001), serum triglycerides (p<0.0001), impaired fasting glucose (p=0.005), and diabetes (p=0.02). These associations generally remained significant after adjustment for BMI and WC (all p-values<0.05), but not after VAT adjustment. Thoracic aortic fat was associated with thoracic calcification in models containing VAT (OR 1.31, 95% CI 1.01-1.71, p=0.04), but was not significant after adjustment for CVD risk factors (OR 1.16, 95% CI 0.88-1.51, p=0.30). Thoracic aortic fat, however, was associated with abdominal aortic calcification (OR 1.48, 95% CI 1.11-1.98, p=0.008) and coronary artery calcification (OR 1.47, 95% CI 1.09-1.98, p=0.001) even in models including CVD risk factors and VAT. CONCLUSIONS: Thoracic peri-aortic fat is associated with measures of adiposity, metabolic risk factors, and coronary and abdominal aortic calcification.
Authors: Scott A Lear; Karin H Humphries; Simi Kohli; Jiri J Frohlich; C Laird Birmingham; G B John Mancini Journal: Stroke Date: 2007-08-02 Impact factor: 7.914
Authors: László B Tankó; Yu Z Bagger; Peter Alexandersen; Philip J Larsen; Claus Christiansen Journal: Circulation Date: 2003-03-17 Impact factor: 29.690
Authors: Caroline S Fox; Joseph M Massaro; Udo Hoffmann; Karla M Pou; Pal Maurovich-Horvat; Chun-Yu Liu; Ramachandran S Vasan; Joanne M Murabito; James B Meigs; L Adrienne Cupples; Ralph B D'Agostino; Christopher J O'Donnell Journal: Circulation Date: 2007-06-18 Impact factor: 29.690
Authors: Alexander M de Vos; Mathias Prokop; Cornelis J Roos; Matthijs F L Meijs; Yvonne T van der Schouw; Annemarieke Rutten; Petra M Gorter; Maarten-Jan Cramer; Pieter A Doevendans; Benno J Rensing; Marie-Louise Bartelink; Birgitta K Velthuis; Arend Mosterd; Michiel L Bots Journal: Eur Heart J Date: 2007-12-20 Impact factor: 29.983
Authors: Jingzhong Ding; Stephen B Kritchevsky; Tamara B Harris; Gregory L Burke; Robert C Detrano; Moyses Szklo; J Jeffrey Carr Journal: Obesity (Silver Spring) Date: 2008-05-29 Impact factor: 5.002
Authors: Guido A Rosito; Joseph M Massaro; Udo Hoffmann; Frederick L Ruberg; Amir A Mahabadi; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Bret H Goodpaster; Shanthi Krishnaswami; Helaine Resnick; David E Kelley; Catherine Haggerty; Tamara B Harris; Ann V Schwartz; Steven Kritchevsky; Anne B Newman Journal: Diabetes Care Date: 2003-02 Impact factor: 19.112
Authors: Jane J Lee; Alison Pedley; Ido Weinberg; Kathryn A Britton; Joseph M Massaro; Udo Hoffmann; Emily Manders; Caroline S Fox; Joanne M Murabito Journal: Am J Cardiol Date: 2017-01-25 Impact factor: 2.778
Authors: Amit Pursnani; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; Udo Hoffmann Journal: JAMA Date: 2015-07-14 Impact factor: 56.272
Authors: Kelly J Shields; Emma Barinas-Mitchell; Matthew R Gingo; Ping Tepper; Bret H Goodpaster; Amy H Kao; Susan Manzi; Kim Sutton-Tyrrell Journal: Atherosclerosis Date: 2013-09-11 Impact factor: 5.162
Authors: Samar R El Khoudary; Kelly J Shields; Imke Janssen; Carrie Hanley; Matthew J Budoff; Emma Barinas-Mitchell; Susan A Everson-Rose; Lynda H Powell; Karen A Matthews Journal: J Clin Endocrinol Metab Date: 2015-07-15 Impact factor: 5.958
Authors: Amit Pursnani; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; Udo Hoffmann Journal: J Clin Oncol Date: 2017-07-12 Impact factor: 44.544